Clinical Trial Update: Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma

View source ↗

Summary

A multicentre study validates vascular biomarkers from tumors as predictors of survival in glioblastoma. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Juan M Garcia-Gomez | Conditions: Glioblastoma | Status: COMPLETED